Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • C vs MRNA✓SelectedUSD · MRNAC vs MRNA performance historyLatest closeAs of-1.14%11/17
Stock and ETF performance explorer

C vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+24.7%
MRNA return
+744.1%
Excess return
-719.4%
Maximum drawdown
-17.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.1%-3.9%+2.8%-1.1%
7D-1.9%-17.6%+15.6%-1.9%
30D-2.9%-5.1%+2.2%-2.9%
3M-12.9%+220.8%-233.8%-11.5%
6M-1.8%+321.7%-323.5%-3.6%
YTD+4.9%+601.3%-596.3%-2.9%
1Y+24.7%+735.2%-710.5%+10.4%
All+24.7%+744.1%-719.4%+10.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling